Neurotropic Viruses, Astrocytes, and COVID-19
Open Access
- 9 April 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 15, 662578
- https://doi.org/10.3389/fncel.2021.662578
Abstract
At the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in China, causing a new coronavirus disease, termed COVID-19 by the WHO on February 11, 2020. At the time of this paper (January 31, 2021), more than 100 million cases have been recorded, which have claimed over 2 million lives worldwide. The most important clinical presentation of COVID-19 is severe pneumonia; however, many patients present various neurological symptoms, ranging from loss of olfaction, nausea, dizziness, and headache to encephalopathy and stroke, with a high prevalence of inflammatory central nervous system (CNS) syndromes. SARS-CoV-2 may also target the respiratory center in the brainstem and cause silent hypoxemia. However, the neurotropic mechanism(s) by which SARS-CoV-2 affects the CNS remain(s) unclear. In this paper, we first address the involvement of astrocytes in COVID-19 and then elucidate the present knowledge on SARS-CoV-2 as a neurotropic virus as well as several other neurotropic flaviviruses (with a particular emphasis on the West Nile virus, tick-borne encephalitis virus, and Zika virus) to highlight the neurotropic mechanisms that target astroglial cells in the CNS. These key homeostasis-providing cells in the CNS exhibit many functions that act as a favorable milieu for virus replication and possibly a favorable environment for SARS-CoV-2 as well. The role of astrocytes in COVID-19 pathology, related to aging and neurodegenerative disorders, and environmental factors, is discussed. Understanding these mechanisms is key to better understanding the pathophysiology of COVID-19 and for developing new strategies to mitigate the neurotropic manifestations of COVID-19.Funding Information
- Javna Agencija za Raziskovalno Dejavnost RS (P3 310, P3 0083, J3 9266, J3-2515)
This publication has 161 references indexed in Scilit:
- Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous systemJournal of Neuroinflammation, 2013
- Viruses and neurodegenerationVirology Journal, 2013
- Infectious Agents and NeurodegenerationMolecular Neurobiology, 2012
- Viral disruption of the blood–brain barrierTrends in Microbiology, 2012
- Aspects of Astrocyte Energy Metabolism, Amino Acid Neurotransmitter Homoeostasis and Metabolic CompartmentationASN Neuro, 2012
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011
- Rodents as Sentinels for the Prevalence of Tick-Borne Encephalitis VirusVector-Borne and Zoonotic Diseases, 2011
- Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytesJournal of General Virology, 2010
- Reversal of West Nile virus-induced blood–brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitorVirology, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009